RPG Life Sciences Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023
April 28, 2023 at 09:25 am EDT
Share
RPG Life Sciences Limited reported earnings results for the fourth quarter and full year ended March 31, 2023. For the fourth quarter, the company reported sales was INR 1,184.9 million compared to INR 1,038 million a year ago. Revenue was INR 1,203.3 million compared to INR 1,050.6 million a year ago. Net income was INR 103.5 million compared to INR 75.2 million a year ago. Basic earnings per share from continuing operations was INR 6.26 compared to INR 4.55 a year ago. Diluted earnings per share from continuing operations was INR 6.26 compared to INR 4.55 a year ago.
For the full year, sales was INR 5,128.1 million compared to INR 4,401.6 million a year ago. Revenue was INR 5,176.1 million compared to INR 4,431.5 million a year ago. Net income was INR 676.4 million compared to INR 514.8 million a year ago. Basic earnings per share from continuing operations was INR 40.9 compared to INR 31.13 a year ago. Diluted earnings per share from continuing operations was INR 40.9 compared to INR 31.13 a year ago.
RPG Life Sciences Limited is an India-based pharmaceutical company. The Company operates in the domestic and international markets in the formulations, generics, and synthetic active pharmaceutical ingredients (APIs) space. Its business portfolio includes domestic formulations, international formulations and APIs. Its domestic formulation business manufactures and markets branded finished dosage formulations in India. The domestic formulations business has presence in over 10 therapeutic areas, including nephrology, oncology, rheumatology, cardiology, respiratory, nutritional, gastroenterology, and diabetology, among others. The international formulations business is involved in developing, manufacturing and marketing oral solid formulations in the generic and branded generic space across regulated and emerging markets. Its products include Azoran, Mofetyl, Arpimune ME, Azathioprine, Sodium Valproate PR, Nicorandil, Quinfamide, Nicorandil, Haloperidol, Risperidone, and others.
RPG LIFE SCIENCES LIMITED 
